Irinotecan plus capecitabine

DRUG2 trials

Sponsors

National Cancer Center, Korea, Pfizer

Conditions

Breast Cancer MetastaticCarcinoma, Hepatocellular

Phase 2

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

CompletedNCT00532714

National Cancer Center, KoreaBreast Cancer Metastatic

Start: 2006-08-31End: 2011-12-31Updated: 2011-12-30

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

CompletedNCT00635323

PfizerCarcinoma, Hepatocellular

Start: 2002-11-30End: 2005-05-31Target: 73Updated: 2008-04-07